Raif Kadri is appointed Vice President Global Sales of PurCann Pharma

Quebec City, January 27, 2021 – The President of PurCann Pharma, Hugo St-Laurent, is proud to announce the appointment of Mr. Raif Kadri as Vice-President Global Sales of PurCann Pharma.

Active in sales to the global pharmaceutical industry for the past 25 years, Mr. Kadri, a biochemist by education, has been in charge of sales at SiliCycle Inc. for the past 15 years and will maintain this position jointly. With his team, he has been able to quadruple the company’s sales on all continents. More recently, he has developed sales teams in India and Europe. Mr. Kadri is currently working on setting up a specific sales team for PurCann Pharma.

PurCann Pharma is positioning itself to become a leader in the extraction and purification of molecules of interest from hemp and cannabis. The company’s management team is currently in a very active phase, confident that the future of cannabis-derived products for medical purposes will be promising and will bring higher growth in uses than recreational use, and this, in the very short term.

About PurCann Pharma
PurCann Pharma is positioning itself to become a leader in the extraction and purification of molecules from hemp and cannabis. The company believes that the future of cannabis-derived products for medical purposes will bring higher growth in use than recreational use in the very short term. The company focuses its efforts on various cannabinoids such as THC and CBD, but also on those with beneficial effects on stress, anxiety, pain, insomnia and certain dermatological conditions. PurCann Pharma’s goal is to obtain pure, high quality extracts, free of pesticides and other undesirable molecules.
> learn more about PurCann Pharma